ASRCX
Price
$8.15
Change
+$0.03 (+0.37%)
Updated
Jun 6 closing price
Net Assets
365.5M
MGLCX
Price
$16.48
Change
+$0.08 (+0.49%)
Updated
Jun 6 closing price
Net Assets
2.28B
Interact to see
Advertisement

ASRCX vs MGLCX

Header iconASRCX vs MGLCX Comparison
Open Charts ASRCX vs MGLCXBanner chart's image
Invesco Global Real Estate Income C
Price$8.15
Change+$0.03 (+0.37%)
VolumeN/A
Net Assets365.5M
MFS Global Real Estate C
Price$16.48
Change+$0.08 (+0.49%)
VolumeN/A
Net Assets2.28B
ASRCX vs MGLCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASRCX vs. MGLCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRCX is a Buy and MGLCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLCX has more cash in the bank: 2.28B vs. ASRCX (366M). ASRCX pays higher dividends than MGLCX: ASRCX (2.68) vs MGLCX (1.30). ASRCX was incepted earlier than MGLCX: ASRCX (18 years) vs MGLCX (10 years). ASRCX (2.01) and MGLCX (1.95) have similar cost to investors . ASRCX (49.00) and MGLCX (48.00) have comparable annual turnover. ASRCX (1000) and MGLCX (1000) have matching initial minimum investment requirements. ASRCX annual gain was more profitable for investors over the last year : 3.46 vs. MGLCX (2.14). ASRCX return over 5 years is better than : 11.11 vs. MGLCX (5.55).
ASRCXMGLCXASRCX / MGLCX
Total Expense Ratio2.011.94104%
Annual Report Gross Expense Ratio2.011.95103%
Fund Existence18 years10 years-
Gain YTD3.4071.863183%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets366M2.28B16%
Annual Yield % from dividends2.681.30206%
Returns for 1 year3.462.14162%
Returns for 3 years-1.67-12.7913%
Returns for 5 years11.115.55200%
Returns for 10 years15.229.19166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX18.96N/A
N/A
Saratoga Health & Biotechnology A
MSAAX19.04N/A
N/A
Morgan Stanley Inst Passport ovrs eq C
TWCAX113.65N/A
N/A
American Century Select A
DHLTX23.67N/A
N/A
Diamond Hill Select I
SEQFX12.26N/A
N/A
SEI Emerging Markets Equity Y (SIT)